Video

FDA's Compounding Advisory Committee's Effects for Compounding Pharmacists

Lisa Faast, PharmD, pharmacy business specialist and member of Pharmacy Development Services, talks about how the FDA's Compounding Advisory Committee will affect the daily practice of compounding pharmacists.

Lisa Faast, PharmD, pharmacy business specialist and member of Pharmacy Development Services, talks about how the FDA’s Compounding Advisory Committee will affect the daily practice of compounding pharmacists.

This interview was recorded at the Pharmacy Development Services 2015 conference in Orlando, Florida.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Related Content
PCAB Accreditation as a Safety Net: GLP-1 Demand and the Spotlight on Compounding Standards
June 27th 2025

PCAB Accreditation as a Safety Net: GLP-1 Demand and the Spotlight on Compounding Standards

Karen Spano, RPh, HDDP
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
Medical Misinformation Affects Public Understanding of Long COVID
June 27th 2025

Medical Misinformation Affects Public Understanding of Long COVID

Camille Cabas, PharmD
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Diabetes - Image credit: Sherry Young | stock.adobe.com
June 27th 2025

Condition Watch: Diabetes

Kennedy Ferruggia, Assistant Editor Aislinn Antrim, Managing Editor Huiqiao (Melinda) Fan, BSc
Vials and syringe on white table with background windows - Image credit: Davizro Photography | stock.adobe.com
June 27th 2025

Zimislecel Could Pave the Way for a Type 1 Diabetes Cure

Kennedy Ferruggia, Assistant Editor